Drug Profile
Research programme: atherosclerosis and hypertension therapies - Transition Therapeutics
Alternative Names: CETP inhibitors - Transition Therapeutics; Cholesterol ester transfer protein inhibitors - Transition Therapeutics; Cholesteryl ester transfer protein inhibitors - Transition Therapeutics; Renin inhibitors - Transition TherapeuticsLatest Information Update: 08 Mar 2010
Price :
$50
*
At a glance
- Originator Transition Therapeutics
- Class
- Mechanism of Action Cholesterol ester transfer protein inhibitors; Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Hypertension
Most Recent Events
- 08 Mar 2010 Discontinued - Preclinical for Atherosclerosis in Canada (unspecified route)
- 08 Mar 2010 Discontinued - Preclinical for Hypertension in Canada (unspecified route)
- 05 Jun 2008 Preclinical development is ongoing